ストックスクリーナーアプリを入手
3.35
6.42%
-0.23
前日終値:
$3.58
開ける：
$3.53
24時間の取引高:
917.19K
Relative Volume:
1.71
時価総額：
$164.44M
収益：
$226.63M
当期純損益:
$15.38M
株価収益率:
10.47
EPS:
0.32
ネットキャッシュフロー:
$35.61M
1週間 パフォーマンス:
+15.92%
1か月 パフォーマンス:
+20.07%
6か月 パフォーマンス:
+40.76%
1年 パフォーマンス:
-43.12%
1日の値動き範囲:
$3.34
$3.65
1週間の範囲:
$2.71
$3.67
52週間の値動き範囲:
$2.225
$6.055
Puma Biotechnology Inc Stock (PBYI) Company Profile
名前
Puma Biotechnology Inc
セクター
電話
(424) 248-6500
住所
10880 WILSHIRE BLVD., LOS ANGELES, CA
PBYI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PBYI
Puma Biotechnology Inc
|
3.35 | 164.44M | 226.63M | 15.38M | 35.61M | 0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.11B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 74.87B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.83B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 26.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-09-28 | アップグレード | Citigroup | Neutral → Buy |
| 2020-06-25 | 再開されました | BofA/Merrill | Underperform |
| 2019-10-08 | ダウングレード | Goldman | Neutral → Sell |
| 2019-05-10 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-10 | ダウングレード | Citigroup | Buy → Neutral |
| 2019-01-17 | 開始されました | Leerink Partners | Mkt Perform |
| 2019-01-03 | ダウングレード | Guggenheim | Buy → Neutral |
| 2018-11-19 | アップグレード | Goldman | Sell → Neutral |
| 2018-11-02 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2018-11-02 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2018-10-01 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-09-17 | 開始されました | Goldman | Sell |
| 2018-05-11 | 繰り返されました | Stifel | Buy |
| 2017-11-10 | 繰り返されました | Citigroup | Buy |
| 2017-11-10 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-02 | 繰り返されました | Stifel | Buy |
| 2017-09-11 | 繰り返されました | Credit Suisse | Outperform |
| 2017-07-10 | 再開されました | Leerink Partners | Outperform |
| 2017-06-06 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-05-25 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-03-02 | 繰り返されました | RBC Capital Mkts | Sector Perform |
すべてを表示
Puma Biotechnology Inc (PBYI) 最新ニュース
Puma Biotechnology’s (PBYI) Buy Rating Reiterated at HC Wainwright - Defense World
Results: Puma Biotechnology, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance UK
PBYI Stock Rises as Q4 Earnings & Sales Outpace Estimates - Yahoo Finance
Puma Biotechnology: Strong Financial Performance and Strategic Developments Justify Buy Rating - TipRanks
GoodRx Holdings Leads The Charge With These 3 Promising Penny Stocks - Simply Wall St
Puma Biotechnology Inc (PBYI) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Puma Biotechnology Reports Strong Earnings Growth in 2024 - TipRanks
Puma Biotechnology: Hold Rating Amidst Flat Sales Growth and Uncertain Drug Prospects - TipRanks
Puma Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Earnings call transcript: Puma Biotech Q4 2024 beats earnings expectations By Investing.com - Investing.com South Africa
Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
Earnings call transcript: Puma Biotech Q4 2024 beats earnings expectations - Investing.com
Puma Biotech stock rises as Q4 earnings surpass expectations By Investing.com - Investing.com Canada
Puma Biotech stock rises as Q4 earnings surpass expectations - Investing.com
Puma Biotech: Q4 Earnings Snapshot - The Bakersfield Californian
Puma Biotechnology to Present at TD Cowen’s 45th Annual Health Care Conference - BioSpace
Puma Biotechnology Reveals Corporate Strategy at Major Healthcare ConferenceWhat Will CEO Disclose? - StockTitan
Puma Biotechnology Inc expected to post earnings of 10 cents a shareEarnings Preview - TradingView
Investors in Puma Biotechnology (NASDAQ:PBYI) have unfortunately lost 73% over the last five years - Yahoo Finance
Puma Biotechnology, Inc. to Host Earnings Call - ACCESS Newswire
SG Americas Securities LLC Boosts Stock Position in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Puma Biotech's Crucial Full Year Earnings Reveal: Q4 Financial Results Coming February 27 - StockTitan
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)February 5, 2025 - BioSpace
Inside Puma Bio's Latest Executive Compensation Move: Key Details on RSU Grants - StockTitan
Millennium Management LLC Reduces Stake in Puma Biotechnology Inc - GuruFocus.com
JPMorgan Chase & Co. Acquires 30,499 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Puma commences Phase II trial of alisertib for breast cancer treatment - MSN
US Penny Stocks To Watch In January 2025 - Simply Wall St
Zacks Research Analysts Increase Earnings Estimates for PBYI - Defense World
What is Zacks Research's Forecast for PBYI FY2025 Earnings? - MarketBeat
Zacks Research Has Optimistic Outlook of PBYI Q4 Earnings - Defense World
Research Analysts Offer Predictions for PBYI Q4 Earnings - MarketBeat
Barclays PLC Increases Stake in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Is Now The Time To Put Puma Biotechnology (NASDAQ:PBYI) On Your Watchlist? - Yahoo Finance
Jane Street Group LLC Buys 16,374 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Insufficient Growth At Puma Biotechnology, Inc. (NASDAQ:PBYI) Hampers Share Price - Simply Wall St
Zacks Research Has Negative Outlook of PBYI FY2024 Earnings - MarketBeat
Zacks Research Issues Pessimistic Estimate for PBYI Earnings - Defense World
FY2025 EPS Forecast for Puma Biotechnology Raised by Analyst - Defense World
FY2025 EPS Estimate for Puma Biotechnology Lifted by Analyst - MarketBeat
PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer - MSN
VIR Stock Up on Early Safety & Efficacy Data on Two Cancer Candidates - Yahoo Finance
Geode Capital Management LLC Has $2.34 Million Holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Barclays PLC Buys 46,370 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World
Best Momentum Stocks to Buy for January 6th - Yahoo Finance
Best Value Stocks to Buy for January 6th - Yahoo Finance
Puma Biotechnology CEO Alan Auerbach sells $106,656 in stock By Investing.com - Investing.com Australia
Puma Biotechnology's SVP sells $27,208 in stock - Investing.com India
Puma Biotechnology chief commercial officer sells $29,742 in stock By Investing.com - Investing.com Australia
Puma Biotechnology Inc (PBYI) 財務データ
収益
当期純利益
現金流量
EPS
3.13%
1.23%
大文字化:
|
ボリューム (24 時間):